SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Ranbaxy under US lens

Sep 18, 2014 at 04:37 | Source: Calcutta Telegraph News

Mumbai, Sept. 17: Ranbaxy Laboratories today said the US justice department had asked it to disclose the way it priced some drugs it sold in America. The Indian company, in fact, had made a provision of Rs 237.75 crore in the first quarter but had n...

Ranbaxy says U.S. authorities seek information on pricing data

Sep 18, 2014 at 00:45 | Source: FirstPost

MUMBAI (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) said on Wednesday that federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid ...

Ranbaxy Says US Authorities Seek Information on Pricing Data

Sep 17, 2014 at 19:57 | Source: NDTV Profit

Mumbai: Generics drug maker Ranbaxy Laboratories Ltd on Wednesday said federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid program. The company&...

Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy

Sep 16, 2014 at 12:00 | Source: NDTV Profit

Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd...

US-Based Gilead Licenses Hepatitis C Drug to Cipla, Ranbaxy, 5 Others

Sep 15, 2014 at 16:00 | Source: NDTV Profit

New Delhi/Mumbai: US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India....

Ranbaxy relief

Sep 14, 2014 at 12:02 | Source: Calcutta Telegraph News

Sept. 13 (Reuters): Pfizer Inc and Ranbaxy Laboratories on Friday won dismissal of a US anti-trust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. US District Judge Peter Sheridan ...

Pfizer, Ranbaxy Win Dismissal of Lawsuit Over Generic Lipitor

Sep 13, 2014 at 12:00 | Source: NDTV Profit

Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of a US antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. US District Judge Peter Sheridan in...

CCI Says Sun's Takeover of Ranbaxy May Hurt Competition

Sep 04, 2014 at 20:00 | Source: NDTV Profit

Mumbai: India's antitrust regulator said on Thursday it had made an initial observation that Sun Pharmaceutical Industries Ltd's agreed $3.2 billion acquisition of Ranbaxy Laboratories Ltd could hurt competition, asking the companies ...

Ranbaxy Falls 2% on Reports of Rs 240 Crore US Fine

Aug 22, 2014 at 12:00 | Source: NDTV Profit

Shares in Ranbaxy Laboratories fell over 2 per cent on Friday after a newspaper report said that the state of Texas has imposed a fine of Rs 240 crore on the company. The fine, the report says, relates to slippages from the US-prescribed manufacturin...

Nifty retreats from record high on profit taking

Aug 21, 2014 at 00:51 | Source: FirstPost

MUMBAI (Reuters) - The Nifty edged lower on Wednesday, unable to sustain a rally after hitting a third consecutive record high earlier in session as investors took profits in blue-chips such as Oil and Natural Gas Corp(ONGC.NS).The falls ended a six-...

Pharma Shares Buck Stock Market Trend, Lead Gainers

Aug 20, 2014 at 16:00 | Source: NDTV Profit

Drug makers rose today bucking the stock market trend as investors seek defensives. Ranbaxy Laboratories was up 4 per cent, while Sun Pharmaceutical Industries gained 4.2 per cent after marking an all-time high of Rs 839. Glenmark Pharmaceuticals&...

Sun bid to address monopoly concern

Aug 14, 2014 at 04:07 | Source: Calcutta Telegraph News

Mumbai, Aug. 13: Sun Pharma today said it was in discussion with the Competition Commission of India (CCI) to allay apprehensions about the impact of its acquisition of Ranbaxy Laboratories on the domestic pharmaceutical sector. The fair trade watch...

Ranbaxy suffers loss

Jul 31, 2014 at 01:52 | Source: Calcutta Telegraph News

Mumbai, July 29: Ranbaxy Laboratories has suffered a net loss of Rs 185.92 crore for the quarter ended June 30 as it was bogged down by a “settlement provision’’ of nearly Rs 237.75 crore. The company, which is dealing with an impo...

Sun Pharma to Seek Shareholders' Nod for Ranbaxy Acquisition

Jul 30, 2014 at 22:00 | Source: NDTV Profit

New Delhi: Mumbai-based Sun Pharmaceutical Industries will seek shareholders' approval for its $4-billion acquisition of Ranbaxy Laboratories in a court-convened meeting on August 22. In a filing to the BSE, the company said the meeting would...

Ranbaxy Laboratories Posts Loss of Rs 186 Crore in June Quarter

Jul 29, 2014 at 19:59 | Source: NDTV Profit

Mumbai: Ranbaxy Laboratories Ltd, which has agreed to be acquired by local rival Sun Pharmaceutical Industries Ltd, posted a net loss in the June quarter hit by a one-time provision. The Indian drug maker has been slapped with a slew of regulatory&am...

Ipca halts drug exports to US

Jul 25, 2014 at 08:12 | Source: Calcutta Telegraph News

Mumbai, July 24: Ipca Laboratories today said it was voluntarily suspending shipments of drug ingredients from one of its plants in the country, following concerns expressed by the US Food and Drug Administration (FDA). The mid-sized company said th...

Sun Pharma pops buyout pill again

Jul 17, 2014 at 03:47 | Source: Calcutta Telegraph News

Mumbai, July 16: After a blockbuster deal to acquire Ranbaxy Laboratories, Sun Pharma today announced that it was buying US-based Pharmalucence Inc for an undisclosed amount. Pharmalucence, which has sterile injectable capacity in the US, has been a...

India supplies pharma to 200 countries; but heavily dependent itself on imports from China: ASSOCHAM Study

Jul 04, 2014 at 20:17 | Source: Assocham

Alongside India building an unenviable reputation of being the pharmacy of the world supplying reliable and affordable medicines to over 200 countries, lesser known fact is that the country has become heavily import dependent on China when it comes ...

US booster dose for Ranbaxy

Jun 28, 2014 at 12:37 | Source: Calcutta Telegraph News

Mumbai, June 27: Ranbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell Valsartan tablets in the American market. Valsartan is the generic version of Novartis’s Diovan, a highly successful drug with ...

Infosys launches solution to tap clinical trial market

Jun 05, 2014 at 05:47 | Source: Economic Times

NEW DELHI: The country's second largest software services firm Infosys today launched a cloud-based version of its clinical trial supply management solution (CTSM) that will offer pharmaceutical firms reduced cost and faster time to market the new d...

video of the day

Oct events litmus test for Nov upswing: Sanju Verma

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.